| Teva Pharma AG - Denosumab-Teva onco 120 mg / 1.7 ml, Injektionslösung | | 70132 | | 01 | | Denosumab-Teva onco 120 mg / 1.7 ml | | Injektionslösung | | M05BX04 | | Denosumab | | 10.12.2025 | | |
| | Composition | | denosumabum 120 mg, natrii acetas trihydricus corresp. natrium 0.49 mg, acidum aceticum glaciale, sorbitolum 79.9 mg, polysorbatum 20, aqua ad iniectabile q.s. ad solutionem pro 1.7 ml. | | Packungsbestandteile | | | | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | | | | A | SL | No | | 002 | 3 | | | A | | No |
|
|
